Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
AGILE THERAPEUTICS INC (AGRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/09/2023 |
8-K
| Investor presentation |
05/24/2022 |
8-K
| Quarterly results |
01/10/2022 |
8-K
| Investor presentation, Credit agreement amendment
Docs:
|
"Sales Agreement",
"CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AGILE THERAPEUTICS, INC. AGILE THERAPEUTICS, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware , does hereby certify as follows: FIRST: The name of the Corporation is Agile Therapeutics, Inc. The Amended and Restated Certificate of Incorporation was originally filed with the Secretary of State of the State of Delaware on May 29, 2014 . SECOND: The first sentence of Article IV, Section A, of the Certificate of Incorporation is hereby amended and restated in its entirety as follows "The total number of shares of stock which the Corporation shall have authority to issue is 310,000,000, divided into two classes: 10,000,000 shares of Preferred Stock, par value $0....",
"Letter re: Agile Therapeutics, Inc. Registration Statement on Form S-3",
"Waiver and Second Amendment to Credit Agreement and Guaranty",
"Agile Therapeutics, Inc. Corporate Presentation" |
|
09/10/2021 |
8-K
| Quarterly results |
01/14/2021 |
8-K
| Quarterly results |
01/08/2020 |
8-K
| Investor presentation |
01/07/2019 |
8-K
| Investor presentation |
11/03/2017 |
8-K
| Investor presentation |
10/16/2017 |
8-K
| Quarterly results |
08/02/2017 |
8-K
| Investor presentation |
05/08/2017 |
8-K
| Form 8-K - Current report |
05/02/2017 |
8-K
| Form 8-K - Current report |
03/16/2017 |
8-K
| Form 8-K - Current report |
01/03/2017 |
8-K
| Form 8-K - Current report |
07/13/2016 |
8-K
| Form 8-K - Current report |
09/08/2015 |
8-K
| Investor presentation |
|
|